John Northcott, SVP & Chief Commercial Officer at NEKTAR THERAPEUTICS (NKTR), sold 12,170 shares at $18.30 ($223K) on 2021-05-17, disclosed to the SEC on 2021-05-19.
Open-market sale of $223k NKTR by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.30 | 6,085 | $111K | 50.0% |
| 2 | $18.30 | 6,085 | $111K | 50.0% |
| Total | $18.30 avg | 12,170 | $223K | 100% |
| Filing → |
| NKTR | SELL | 2021-11-17 | $160K | — | Filing → |
| NKTR | SELL | 2021-08-18 | $171K | — | Filing → |
| NKTR | SELL | 2021-02-18 | $687K | — | Filing → |